| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2006 | US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
| 06/06/2006 | US7057036 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7056954 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 06/06/2006 | US7056952 Isoflavone metabolites |
| 06/06/2006 | US7056951 Stabilizers to inhibit the formation of a lactam, comprising a composition that is known to reduce ionic activity (such as an alcohol, ketone, stearate or cellulose derivative); and at least 20 ppm of an anion. |
| 06/06/2006 | US7056950 Compositions of biochemical compounds involved in bioenergy metabolism of cells |
| 06/06/2006 | US7056949 Liver disorders, dietetics; weight ratio of glycerides to diglycerides |
| 06/06/2006 | US7056947 For inhibiting (cysteine) proteases/caspases; for treatment of viral infections, stroke, neurodegenerative disease, and inflammatory diseases |
| 06/06/2006 | US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8) |
| 06/06/2006 | US7056945 Selective inhibition of neuronal nitric oxide synthase |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056942 Carvedilol |
| 06/06/2006 | US7056940 effective in controlling lepidoptera, coleoptera, mites and other sucking pests |
| 06/06/2006 | US7056939 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3) |
| 06/06/2006 | US7056938 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056936 Synergistic combination |
| 06/06/2006 | US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 06/06/2006 | US7056934 use in treating respiratory system disorders such as asthma, incipient asthma and wheezy infant syndrome, chronic or acute bronchoconstriction, chronic bronchitis, small airways obstruction, emphysema, chronic eosinophilic pneumonia, chronic obstructive pulmonary disease, allergies |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides |
| 06/06/2006 | US7056931 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 06/06/2006 | US7056930 for treatment of disease states, disorders and conditions mediated by opioid receptors; for example, irritable bowel syndrome, drug addiction, including alcohol addiction, depression, anxiety, schizophrenia, eating disorders |
| 06/06/2006 | US7056929 Benzo[b]pyrano[3,2-h]acridin-7-one compounds |
| 06/06/2006 | US7056928 anti-inflammatory, anti-pyretic and analgesic properties, without the potential side effects associated with inhibition of COX-1 |
| 06/06/2006 | US7056927 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056925 Urea kinase inhibitors |
| 06/06/2006 | US7056924 Substituted heterocyclic compounds |
| 06/06/2006 | US7056923 Anticoagulants |
| 06/06/2006 | US7056922 Acylamino cyclopropane derivatives |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | US7056920 useful for treating disorders or conditions that are associated with CRF or CRF1 receptors, such as anxiety disorders, depression, and stress related disorders |
| 06/06/2006 | US7056918 Benzimidazole anti-inflammatory compounds |
| 06/06/2006 | US7056917 Prevent drug resistance |
| 06/06/2006 | US7056916 Using a 1,4- benzoxazin-3-one compound |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 06/06/2006 | US7056913 for example, 7-methoxy-8-[n'-(4''-acridonylcarboxyamido)alkyl]-oxy-(11aS)-1,2,3,11a-tetraydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one; antitumor agents |
| 06/06/2006 | US7056912 Heteroaryl derivatives and their use as medicaments |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/06/2006 | US7056910 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056908 Containing indolecarbazole compounds, such as staurosporine. |
| 06/06/2006 | US7056907 Mandelic acid derivatives and their use as thrombin inhibitors |
| 06/06/2006 | US7056906 Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| 06/06/2006 | US7056905 Antiinflammatory agents; immunosuppressants |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | US7056901 Microgel particles for the delivery of bioactive materials |
| 06/06/2006 | US7056900 Disaccharide derivatives for treating hyperglycaemia |
| 06/06/2006 | US7056899 Disaccharide derivatives for treating hyperglycaemia |
| 06/06/2006 | US7056898 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 06/06/2006 | US7056895 1-(3,4-dihydroxy-5-methylol-tetrahydrofur-2-yl),3-amidino-1H-1,2,4- triazoles; infections, infestations, autoimmune diseases; anticarcinogenic and -tumor agents; HIV, hepatitis C, human papilloma virus and giant cell arteritis |
| 06/06/2006 | US7056894 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof |
| 06/06/2006 | US7056893 Topical treatment for prevention of ocular infections |
| 06/06/2006 | US7056892 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 06/06/2006 | US7056891 Method to produce a tampon that inhibits exoprotein production from gram positive bacteria |
| 06/06/2006 | US7056890 Combination therapy for effecting weight loss and treating obesity |
| 06/06/2006 | US7056889 For modulating mucus production at mucosal surfaces |
| 06/06/2006 | US7056887 Treatment of acute coronary syndrome with GLP-1 |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056707 Culture of aspergillus; 2-amido-3-hydroxy-4-propene-5-methyl-6-methoxybenzoic acid; antihistamines; skin disorders; antiinflammatory agents; antidiabetic agents |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056655 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 06/06/2006 | US7056550 priming the device (e.g., a stent) by dip coating with a hexafluoropropylene-vinylidene fluoride polymer prepared by batch emulsion polymerization; spin coating with a polymer-drug mixture; and drying in a vacuum oven for sixteen hours at a temperature at 15-60 degrees C.; improved biocompatibility |
| 06/06/2006 | US7056529 Vesicle comprises ATP and phospholipid; fusion proteins |
| 06/06/2006 | US7056528 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 06/06/2006 | US7056527 Patches containing buprenorphine hydrochloride |
| 06/06/2006 | US7056525 Use thereof in human and animal foods, cosmetics and pharmaceuticals; soft gelatin capsules |
| 06/06/2006 | US7056524 Methods of hydrating mucosal surfaces |
| 06/06/2006 | US7056520 Method and composition for the treatment of a viral infection |
| 06/06/2006 | US7056501 used to develop diagnostic assays for the detection of Neospora infections in cattle and other animals |
| 06/06/2006 | US7056500 Polymer conjugates of opioid antagonists |
| 06/06/2006 | US7056498 Urea, carbamate and sulfonamide derivatives; oxyalkylenated fatty acid esters of sorbitan, oxyalkylenated hydrogenated castor oils, or oxyalkylenated fatty alcohols |
| 06/06/2006 | US7056493 Radio-opaque polymer biomaterials |
| 06/06/2006 | US7056491 Sensitizing tumor cells with terpene such as perillyl alcohol |
| 06/06/2006 | US7056332 making a suture by modifying an aqueous suspension of a nucleic acid, e.g., by capping, crosslinking, methylation, ethylation, or attachment of a protein, to form a viscous gel, which is extruded to form a filament; optionally adding a biodegradable polymer |
| 06/06/2006 | CA2457852C Multivesicular emulsion topical delivery systems |
| 06/06/2006 | CA2449892C Nutritional supplement to treat macular degeneration |
| 06/06/2006 | CA2417686C Manufacture of oral dosage forms delivering both immediate release and sustained release drugs |
| 06/06/2006 | CA2376706C Antifungal oral composition containing itraconazole and process for preparing same |
| 06/06/2006 | CA2352592C Quinazolinone compounds |
| 06/06/2006 | CA2336582C Novel x-ray intercepting metal complexes of chlorin derivatives |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2316902C Alpha-aminoamide derivatives useful as analgesic agents |
| 06/06/2006 | CA2282585C Pyrazine compounds |
| 06/06/2006 | CA2277951C Imino-aza-anthracyclinone derivatives |
| 06/06/2006 | CA2258895C Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders |
| 06/06/2006 | CA2242577C Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-.beta.-estradiol to the human organism |
| 06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/06/2006 | CA2213810C Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods |
| 06/06/2006 | CA2199468C 1,2,3,4-tetrahydroquinoxalinedione derivative |
| 06/06/2006 | CA2193061C Fractionated polydisperse compositions |
| 06/06/2006 | CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists |
| 06/06/2006 | CA2160775C Transdermal therapeutic system containing estradiol |
| 06/06/2006 | CA2160366C Risperidone pamoate |
| 06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |